CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells

FASEB Journal

Volumn 27, Issue 9, 2013, Pages 3683-3701

  Ghazi Visser, Lizette ^a   Laman, Jon D ^a   Nagel, Sabine ^b   Van Meurs, Marjan ^a   Van Riel, Debby ^a   Tzankov, Alexandar ^b   Frank, Stephan ^b   Adams, Heiner ^b   Wolk, Kerstin ^c   Terracciano, Luigi ^b   Melief, Marie José ^a   Sabat, Robert ^c   Günthert, Ursula ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Multiple sclerosis; Th1

Indexed keywords

CASPASE 3; CD28 ANTIGEN; CD3 ANTIGEN; CD44V ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 27P28; MESSENGER RNA; PROTEIN BCL 2; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GLIA CELL; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY INFILTRATE; MEMORY T LYMPHOCYTE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; WILD TYPE;

APOPTOSIS; MULTIPLE SCLEROSIS; TH1;

ANIMALS; ANTIGENS, CD44; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; MICE; MICE, MUTANT STRAINS; MULTIPLE SCLEROSIS; PROTEIN ISOFORMS; T-LYMPHOCYTES; TH1 CELLS;

EID: 84883312632     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-228809     Document Type: Article

References (61)

1. McFarland, H. F., and Martin, R. (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919
2. Steinman, L. (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 9, 440-447
3. Goverman, J. (2009) Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407
4. Engelhardt, B. (2010) T cell migration into the central nervous system during health and disease: different molecular keys allow access to different central nervous system compartments. Clin. Exp. Neuroimmunol. 1, 79-93
5. Baaten, B. J., Tinoco, R., Chen, A. T., and Bradley, L. M. (2012) Regulation of antigen-experienced T cells: lessons from the quintessential memory marker cD44. Front. Immunol. 3, 23
6. Zöller, M. (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 11, 254- 267
7. Laman, J. D., Maassen, C. B., Schellekens, M. M., Visser, L., Kap, M., de Jong, E., van Puijenbroek, M., van Stipdonk, M. J., van Meurs, M., Schwärzler, C., and Günthert, U. (1998) Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Mult. Scler. 4, 147-153
8. Garin, T., Rubinstein, A., Grigoriadis, N., Nedvetzki, S., Abramsky, O., Mizrachi-Koll, R., Hand, C., Naor, D., and Karussis, D. (2007) CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis. J. Neurol. Sci. 258, 17-26
9. Braitch, M., and Constantinescu, C. S. (2010) The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). Inflamm. Allergy Drug Targets 9, 249-256
10. Kandagaddala, L. D., Kang, M. J., Chung, B. C., Patterson, T. A., and Kwon, O. S. (2012) Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice. Exp. Toxicol. Pathol. 64, 109-114
11. Mackay, C. R., Terpe, H. J., Stauder, R., Marston, W. L., Stark, H., and Günthert, U. (1994) Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124, 71-82
12. Wittig, B. M., Stallmach, A., Zeitz, M., and Günthert, U. (2002) Functional involvement of CD44 variant 7 in gut immune response. Pathobiology 70, 184-189
13. Schwärzler, C., Oliferenko, S., and Günthert, U. (2001) Variant isoforms of CD44 are required in early thymocyte development. Eur. J. Immunol. 31, 2997-3005
14. Johnson, P., and Ruffell, B. (2009) CD44 and its role in inflammation and inflammatory diseases. Inflamm. Allergy Drug Targets 8, 208-220
15. Naor, D., Nedvetzki, S., Walmsley, M., Yayon, A., Turley, E. A., Golan, I., Caspi, D., Sebban, L. E., Zick, Y., Garin, T., Karussis, D., Assayag-Asherie, N., Raz, I., Weiss, L., Slavin, S., and Golan, I. (2007) CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice. Ann. N. Y. Acad. Sci. 1110, 233-247
16. Wittig, B. M., Johansson, B., Zöller, M., Schwärzler, C., and Günthert, U. (2000) Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J. Exp. Med. 191, 2053-2064
17. Hoffmann, U., Heilmann, K., Hayford, C., Stallmach, A., Wahnschaffe, U., Zeitz, M., Günthert, U., and Wittig, B. M. (2007) CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell Death Differ. 14, 1542-1551
18. Brocke, S., Piercy, C., Steinman, L., Weissman, I. L., and Veromaa, T. (1999) Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. U. S. A. 96, 6896- 6901
19. Guan, H., Nagarkatti, P. S., and Nagarkatti, M. (2012) CD44 reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis. J. Immunol. 186, 6955-6964
20. Girgrah, N., Letarte, M., Becker, L. E., Cruz, T. F., Theriault, E., and Moscarello, M. A. (1991) Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J. Neuropathol. Exp. Neurol. 50, 779-792
21. Mycko, M. P., Papoian, R., Boschert, U., Raine, C. S., and Selmaj, K. W. (2003) cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 126, 1048-1057
22. + T cells that induce experimental allergic encephalomyelitis. J. Neuroimmunol. 40, 57-69
23. Wolk, K., Haugen, H. S., Xu, W., Witte, E., Waggie, K., Anderson, M., Vom Baur, E., Witte, K., Warszawska, K., Philipp, S., Johnson-Leger, C., Volk, H. D., Sterry, W., and Sabat, R. (2009) IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not. J. Mol. Med. 87, 523-536
24. Visser, L., de Vos, A. F., Hamann, J., Melief, M. J., van Meurs, M., van Lier, R. A., Laman, J. D., and Hintzen, R. Q. (2002) Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. J. Neuroimmunol. 132, 156-163
25. Van der Valk, P., and De Groot, C. J. (2000) Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 26, 2-10
26. Laman, J. D., van Meurs, M., Schellekens, M. M., de Boer, M., Melchers, B., Massacesi, L., Lassmann, H., Claassen, E., and Hart, B. A. (1998) Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J. Neuroimmunol. 86, 30-45
27. + regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 193, 1-11
28. Aheng, C., Ly, N., Kelly, M., Ibrahim, S., Ricquier, D., Alves-Guerra, M. C., and Miroux, B. (2011) Deletion of UCP2 in iNOS deficient mice reduces the severity of the disease during experimental autoimmune encephalomyelitis. PLoS One 6, e22841
29. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K., and Flavell, R. A. (2006) Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24, 99-146
30. Huss, D. J., Winger, R. C., Cox, G. M., Guerau-de-Arellano, M., Yang, Y., Racke, M. K., and Lovett-Racke, A. E. (2011) TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur. J. Immunol. 41, 2987-2996
31. Domingues, H. S., Mues, M., Lassmann, H., Wekerle, H., and Krishnamoorthy, G. (2010) Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One 5, e15531
32. Wittig, B., Seiter, S., Schmidt, D. S., Zuber, M., Neurath, M., and Zöller, M. (1999) CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases. Lab. Invest. 79, 747-759
33. Wittig, B., Seiter, S., Föger, N., Schwärzler, C., Günthert, U., and Zöller, M. (1997) Functional activity of murine CD44 variant isoforms in allergic and delayed type hypersensitivity. Immunol. Lett. 57, 217-223
34. Nandi, A., Estess, P., and Siegelman, M. (2004) Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20, 455-465
35. Mielgo, A., van Driel, M., Bloem, A., Landmann, L., and Günthert, U. (2006) A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms. Cell Death Differ. 13, 465-477
36. Crispin, J. C., Keenan, B. T., Finnell, M. D., Bermas, B. L., Schur, P., Massarotti, E., Karlson, E. W., Fitzgerald, L. M., Ergin, S., Kyttaris, V. C., Tsokos, G. C., and Costenbader, K. H. (2011) Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. Arthritis Rheum. 62, 1431-1437
37. Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., and Laman, J. D. (2006) Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129, 517-526
38. + T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 181, 7480-7488
39. Rothhammer, V., Heink, S., Petermann, F., Srivastava, R., Claussen, M. C., Hemmer, B., and Korn, T. (2011) Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J. Exp. Med. 208, 2465- 2476
40. Kleine, T. O., and Benes, L. (2006) Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons. Cytometry A 69, 147-151
41. Zheng, Y., and Rudensky, A. Y. (2007) Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457-462
42. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., Oukka, M., and Kuchroo, V. K. (2007) Myelinspecific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431
43. Michel, L., Berthelot, L., Pettre, S., Wiertlewski, S., Lefrere, F., Braudeau, C., Brouard, S., Soulillou, J. P., and Laplaud, D. A. (2008) Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor α-chain are excluded from the analysis. J. Clin. Invest. 118, 3411-3419
44. + regulatory T cells in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 192, 57-67
45. Zhu, B., Symonds, A. L., Martin, J. E., Kioussis, D., Wraith, D. C., Li, S., and Wang, P. (2008) Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J. Exp. Med. 205, 2295-2307
46. + T cells in experimental autoimmune encephalomyelitis. Am. J. Pathol. 173, 411-422
47. +CD44hi cells. Immunity 29, 758-770
48. Chu, C. Q., Wittmer, S., and Dalton, D. K. (2000) Failure to suppress the expansion of the activated CD4 T cell population in interferon α-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123- 128
49. Maniati, E., Potter, P., Rogers, N. J., and Morley, B. J. (2008) Control of apoptosis in autoimmunity. J. Pathol. 214, 190-198
50. Strasser, A., Jost, P. J., and Nagata, S. (2009) The many roles of FAS receptor signaling in the immune system. Immunity 30, 180-192
51. Soilu-Hanninen, M., Laaksonen, M., and Hanninen, A. (2005) Hyaluronate receptor (CD44) and integrin α4 (CD49d) are up-regulated on T cells during MS relapses. J. Neuroimmunol. 166, 189-192
52. Kaaijk, P., Pals, S. T., Morsink, F., Bosch, D. A., and Troost, D. (1997) Differential expression of CD44 splice variants in the normal human central nervous system. J. Neuroimmunol. 73, 70-76
53. Haegel, H., Tölg, C., Hofmann, M., and Ceredig, R. (1993) Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J. Cell Biol. 122, 1067-1077
54. + lymphocytes to dermal microvascular endothelial cells and keratinocytes. J. Invest. Dermatol. 117, 949-957
55. Yoshinari, C., Mizusawa, N., Byers, H. R., and Akasaka, T. (1999) CD44 variant isoform CD44v10 expression of human melanoma cell lines is upregulated by hyaluronate and correlates with migration. Melanoma Res. 9, 223-231
56. Seiter, S., Engel, P., Föhr, N., and Zöller, M. (1999) Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: blockade of leukocyte egress. J. Invest. Dermatol. 113, 11-21
57. Haegel-Kronenberger, H., de la Salle, H., Bohbot, A., Oberling, F., Cazenave, J. P., and Hanau, D. (1998) Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. J. Immunol. 161, 3902-3911
58. Mix, E., Meyer-Rienecker, H., Hartung, H. P., and Zettl, U. K. (2010) Animal models of multiple sclerosis - potentials and limitations. Prog. Neurobiol. 92, 386-404
59. Runnels, H. A., Weber, G. L., Min, J., Kudlacz, E. M., Zobel, J. F., Donovan, C. B., Thiede, M. A., Zhang, J., Alpert, R. B., Salafia, M. A., Milici, A. J., Burdette, D., Bell, R. R., Beebe, J. S., and Xu, X. (2010) PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases. Adv. Ther. 27, 168-180
60. Ghosh, S. C., Neslihan Alpay, S., and Klostergaard, J. (2012) CD44: a validated target for improved delivery of cancer therapeutics. Expert Opin. Ther. Targets 16, 635-650
61. Masuko, K., Okazaki, S., Satoh, M., Tanaka, G., Ikeda, T., Torii, R., Ueda, E., Nakano, T., Danbayashi, M., Tsuruoka, T., Ohno, Y., Yagi, H., Yabe, N., Yoshida, H., Tahara, T., Kataoka, S., Oshino, T., Shindo, T., Niwa, S., Ishimoto, T., Baba, H., Hashimoto, Y., Saya, H., and Masuko, T. (2012) Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells. PLoS One 7, e29728